Independent information resource

Services

Guides, comparisons, and research summaries for soccer players, former players, families, and supporters trying to separate ibogaine-related claims from evidence, legal constraints, and serious safety questions.

Open Almanac is a calm starting point for careful context—not a clinic, medical provider, or treatment center.

Symbolic still-life reflecting careful consideration of ibogaine claims in soccer
Safety before hype. Evidence and context. Plain language.
What we provide

Information built for difficult questions

The material is organized as an independent resource for people navigating uncertainty. Our approach and independence guide how claims, risks, and open questions are framed.

01

In-depth guides

Topic guides set the soccer context first: head impacts, mental health concerns, addiction-related discussions, and the limits of what can responsibly be inferred. The ibogaine and soccer overview helps locate these conversations without treating them as settled medical answers.

02

Decision frameworks

Practical frameworks identify questions worth asking before anyone acts on a claim: what evidence exists, what risks are named, what legal setting applies, and where clinical judgment is required. Context from U.S. treatment discussions is presented as background, not a recommendation.

03

Comparisons in plain language

Comparisons help readers notice where two ideas are actually different, where marketing language blurs important distinctions, and where research cannot yet support a conclusion. A contrast such as ibogaine versus mushrooms belongs in a broader discussion of substance-specific risks and uncertainty.

04

Research summaries and glossary

Research summaries translate technical language without converting early findings into promises. A glossary clarifies terms that may appear in discussions of what ibogaine does, while keeping mechanisms, effects, and outcomes clearly separate.

A careful reading path

From a striking claim to useful context

Ibogaine is associated with substantial safety and legal concerns. The U.S. Drug Enforcement Administration lists ibogaine as a Schedule I controlled substance, a status that matters when evaluating claims and choices in the United States.

  1. 1 Start with the question.
    Identify whether the concern is addiction, mental health, post-career transition, head impacts, or a broader search for relief.
  2. 2 Check the claim.
    Use material such as questions about whether treatment works to distinguish an outcome claim from the evidence actually offered.
  3. 3 Keep safety in view.
    Comparative and cost-oriented language, including discussion of affordable treatment options, should never obscure medical risk, regulation, or the need for qualified professional advice.
Abstract image accompanying a step-by-step approach to evaluating ibogaine claims
Evidence with boundaries

Research summaries that preserve uncertainty

Our summaries are designed to make the difference between a hypothesis, an early finding, a clinical claim, and a personal account visible. Background on the ibogaine compound can help explain why its history is often discussed alongside treatment claims, but it does not establish safety or effectiveness for any individual.

When people compare providers or narratives, we encourage attention to the limits of promotional material, including claims made around a best treatment clinic. For soccer stakeholders, careful interpretation is more useful than a ranking or a promise.

“The useful service is not certainty on demand. It is a clearer view of what is known, what is disputed, and what carries meaningful risk.”
Open Almanac’s evidence-first approach

Keep the soccer context in the frame

Return to the main ibogaine-for-soccer resource for the wider context, or use the FAQ collection when a question needs a direct, cautious answer.

Explore stakeholder FAQs